UNSPSC 51263142: Flestolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C15H22FN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LI02075E1W, chemically known as [3-[[1-(carbamoylamino)-2-methylpropan-2-yl]amino]-2-hydroxypropyl]2-fluorobenzoate but generally known as flestolol, which bears US NIH Compound Identifier 55885. European Medicines Agency schedules flestolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07641MIG.

Most nations schedule flestolol under HS 29242190 and SITC 51473. As of Q4 2014, FLESTOLOL remains the US FDA Preferred Term for this commodity. Flestolol bears US NLM identifiers UMLS ID C0060455 and NCI Concept Code C72784. SMILES: CC(C)(CNC(=O)N)NCC(COC(=O)C1=CC=CC=C1F)O.

UNSPSC 51263142 Flestolol is a Commodity code under which state and local governments procure pharmaceutical products and drug-related medical supplies. The recent solicitation record shows Seminole County, Florida seeking naloxone and safe drug deactivation systems—products aligned with community health and harm-reduction initiatives rather than the pharmaceutical compound nominally named in the code. State and local buyers appear to use this code for emergency medical countermeasures and public-health pharmaceutical supplies distributed through community health programs. Issuing bodies soliciting under this code include county health departments and special-purpose health authorities managing substance-abuse response and overdose-prevention operations.

Seminole County, Florida represents the geographic footprint in the available recent-opportunity record. The representative current opportunity is Seminole County's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2026, for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract carries a two-year initial term with one-year renewal option, fixed-fee pricing, and a three-month probationary termination clause. Bidders must meet E-Verify compliance, drug-free workplace certification, and carry workers' compensation and professional liability insurance. The procurement is potentially FEMA-funded, introducing federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. No explicit set-asides for disadvantaged enterprises are named in the solicitation.